期刊文献+
共找到1,810篇文章
< 1 2 91 >
每页显示 20 50 100
Detection of expression of vascular endothelial growth factor C/VEGFR-3 in early stage cervical cancer by tissue microarray assay and its significance 被引量:1
1
作者 SHANG Hai-xia WU Su-hui LI Ying 《山西医科大学学报》 CAS 2009年第9期845-849,共5页
关键词 早期子宫癌 诊断 淋巴结转移 动脉血管
在线阅读 下载PDF
THE EXPRESSIONS AND SIGNIFICANCES OF p15,p16 AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN GASTRIC CARCINOMA
2
作者 王天宝 高鹏 +2 位作者 曲延刚 陈咸增 李兆亭 《中国现代普通外科进展》 CAS 2000年第2期29-31,共3页
To investigate the relationships between the expressions of p15,p16 and vascular endothelial growth factor (VEGF) and gastric carcinoma(GC). Methods: Using Immunohistochemical staining to examine the expressions of p1... To investigate the relationships between the expressions of p15,p16 and vascular endothelial growth factor (VEGF) and gastric carcinoma(GC). Methods: Using Immunohistochemical staining to examine the expressions of p15, p16 and VEGF In archival wax-embedded specimens of 80 GC and 20 gastric benign disease (GBD). Results: The positive expression rate (PER) of p15 was significantly lower in GC than in GBD (43.75% VS. 69.23%, P<0.05). No relationship was found between PER of p15 and clinicopathologic factors. PER of p16 was 20% in GC, 55% in GBD (P<0.01). PER of p16 wasn't significantly different in gross types, histological types, with or without distant metastasis and pTNM stages. PER of p16 was 71.43% in invasive mucosa or submucosa group, 17.24% in invasive muscle group and 13.64% in invasive serosa group (P<0.01); 12.96% in GC with lymph nodes metastasis, 34.62% in GC without lymph node metastasis (P<0.05). PER of VEGF in GC was 75.00%, in GBD 7.69% (P<0.001), in ul-cerative type of GC and infiltrating 展开更多
关键词 P15基因 p16基因 胃癌 血管内皮生长因子 免疫组织化学 基因表达 肿瘤生物学
在线阅读 下载PDF
Effects of bone marrow-derived mesenchymal stemcells engraftment on vascular endothelial cell growthfactor in lung tissue and plasma at early stage of smoke inhalation injury 被引量:5
3
作者 FengZhu Guang-hua Guo +1 位作者 Wen Chen Nian-yun Wang 《World Journal of Emergency Medicine》 SCIE CAS 2010年第3期224-228,共5页
BACKGROUND: This study was undertaken to determine the effect of mesenchymal stem cells (MSCs) engraftment on vascular endothelial cell growth factor (VEGF) in lung tissue, plasma and extravascular lung water at... BACKGROUND: This study was undertaken to determine the effect of mesenchymal stem cells (MSCs) engraftment on vascular endothelial cell growth factor (VEGF) in lung tissue, plasma and extravascular lung water at early stage of smoke inhalation injury.METHODS: A rabbit smoke inhalation injury model was established using a home-made smoke inhalation injury generator, and rabbits were divided into two groups randomly: a control group (S group, n=32) and a MSCs treatment group (M group, n=32). 10 ml PBS was injected via the ear marginal vein immediately at injury into the S group. Third generation MSCs with a concentration of 1×107/10 ml PBS were injected via the ear marginal vein immediately at injury into the M group. VEGF in peripheral blood and lung tissue were measured at 0 (baseline), 2, 4 and 6 hours after injection respectively and analyzed. The right lungs of rabbits were taken to measure lung water mass fraction.RESULTS: In the lung tissue, VEGF decreased gradually in the S group (P〈0.05) and signi? cantly decreased in the M group (P〈0.05), but it increased more signi? cantly than the values at the corresponding time points (P〈0.05). In peripheral blood, VEGF increased gradually in the S group (P〈0.05) and markedly increased in the M group (P〈0.05), but it decreased more signi? cantly than the values at corresponding time points (P〈0.05).CONCLUSION: MSCs engraftment to smoke inhalation injury could increase VEGF in lung tissue, decrease VEGF in plasma and reduce extravascular lung water, indicating its protective effect on smoke inhalation injury. 展开更多
关键词 Mesenchymal stem cells Smoke inhalation injury vascular endothelial cell growth factor Extravascular lung water Rabbit
在线阅读 下载PDF
SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATIENTS WITH ANGINA PECTORIS AND ACUTE MYOCARDIAL INFARCTION 被引量:5
4
作者 尹瑞兴 冯建章 +1 位作者 陈旦红 乌汉东 《Chinese Medical Sciences Journal》 CAS CSCD 2000年第4期205-209,共5页
Objective. To determine whether serum vascular endothelial growth factor(VEGF)concentrations are altered in several kinds of coronary heart disease patients. Materials and methods. Using a VEGF enzyme-linked immunosor... Objective. To determine whether serum vascular endothelial growth factor(VEGF)concentrations are altered in several kinds of coronary heart disease patients. Materials and methods. Using a VEGF enzyme-linked immunosorbent assay(ELISA), serum VEGF concentrations were determined in antecubital venous blood of 16 patients with stable angina pectoris(SAP), 16 with unstable angina pectoris(UAP) and 16 with acute myocardial infarction(AMI) before and after thrombolytic therapy, and of 16 age- and sex-matched healthy volunteers who used as controls. Results. The concentrations of serum VEGF in patients with SAP(9860±2699pg/ml) and UAP (10361±2489pg/ml) tended to be higher than those in control subjects(8044±2457pg/ml), but the differences did not reach statistical significance (P>005 for each). Before thrombolytic therapy, the concentrations of serum VEGF in patients with AMI (28592±12515pg/ml) were significantly higher than those in patients with SAP, UAP or control subjects (P<001,respectively), and correlated with synchronous serum creatine kinase (CK) and its MB isoenzyme (CK-MB) contents(r=0866,P<0001 and r=0948,P<0001;respectively). Three hours after thrombolysis, the concentrations of VEGF had fallen to 11157±3129pg/ml (P<001 vs. before thrombolytic therapy and P<005 vs.control subjects). Conclusion. The present study shows that serum concentrations of VEGF in patients with AMI are markedly elevated and that increased serum VEGF levels may be one of the most sensitive indexes in diagnosing AMI and judging reperfusion. 展开更多
关键词 angina pectoris myocardial infarction vascular endothelial growth factor
在线阅读 下载PDF
Zinc Finger Protein-activating Transcription Factor Up-regulates Vascular Endothelial Growth Factor-A Expression in Vitro 被引量:2
5
作者 Li-shan Lian Yao-guo Yang +4 位作者 Wei Liu Li-long Guo Heng Guan Chang-wei Liu Yong-jun Li 《Chinese Medical Sciences Journal》 CAS CSCD 2012年第3期171-175,共5页
Objective To construct the zinc finger protein-activating transcription factor (ZFP-ATF) plasmid and evaluate its efficacy in inducing vascular endothelial growth factor (VEGF) expression in EY.HY926 endothelial cells... Objective To construct the zinc finger protein-activating transcription factor (ZFP-ATF) plasmid and evaluate its efficacy in inducing vascular endothelial growth factor (VEGF) expression in EY.HY926 endothelial cells. Methods Firstly, we constructed the ZFP-ATF plasmid, then testified the quantity of VEGF protein in EY.HY926 endothelial cells after transfected with ZFP-ATP plasmid by Western blot, finally, we used the RT-PCR to testify whether the ZFP-ATF can stimulate expression of VEGF splice variants. Results The ZFP-ATF DNA sequences were located the multiclone sites of PVAX1 vector between the site of BamH Ⅰ and Xhol. Western blot result showed VEGF expression in EY.HY926 endothelial cells transfected with ZFP-ATF plasmid was significantly higher than that in cells transfected with VEGF165 (19.95±3.95 vs. 12.15±1.55 μg/μL, P<0.01). RT-PCR result showed VEGF-A mRNA expression level induced by ZFP-ATF was high than that induced by VEGF165. Conclusion ZFP-ATF can up-regulate the VEGF-A expression in comparison with VEGF165, which might have beneficial effects in angiogenesis process. 展开更多
关键词 zinc finger protein-activating transcription factor vascular endothelial growth factor ANGIOGENESIS
在线阅读 下载PDF
DYNAMIC CHANGES OF SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS IN A RAT MYOCARDIAL INFARCTION MODEL 被引量:2
6
作者 尹瑞兴 冯建章 姚震 《Chinese Medical Sciences Journal》 CAS CSCD 2000年第3期154-156,共3页
To investigate the dynamic changes of serum vascular endothelial growth factor(VEGF) levels in a rat model of acute myocardial infarction. Materials and methods.Eighty eight adult male Sprague Dawley rats weighing app... To investigate the dynamic changes of serum vascular endothelial growth factor(VEGF) levels in a rat model of acute myocardial infarction. Materials and methods.Eighty eight adult male Sprague Dawley rats weighing approximately 270 g were used in this study. Eighty rats were subjected to left coronary artery ligation, with 8 rats for each different duration of infarct. Eight sham operated animals in which the left coronary artery was surgically exposed without ligation were used as controls. Blood samples were drawn from the right atrium before (sham animals) and 1,3,6,12,24 h and 2,3,5,7,14 d after myocardial infarction. The concentrations of serum VEGF were measured by a sensitive enzyme linked immunosorbent assay with a rabbit polyclonal antibody specific for VEGF. Results. In the 8 control animals, the mean concentration of serum VEGF was 66.99±17.83 pg/ml. Six hours after myocardial infarction, the level of serum VEGF significantly increased to 125.68±28.07 pg/ml (P<0.01 vs. sham controls), and reached a peak (240.61±70.63 pg/ml. P<0.01 vs. sham animals) at 24 h after ligation and then decreased gradually over the remaining 2 weeks. However, the level remained significantly elevated for 14 d (107.64±30.13pg/ml, P<0.01 vs. sham controls). Conclusion. The present study shows that the levels of serum VEGF are markedly increased until 14 d in the rat model of acute myocardial infarction. The increased serum VEGF level may play an important role in the angiogenesis associated with myocardial infarction. 展开更多
关键词 myocardial infarction vascular endothelial growth factor enzyme linked immunosorbent assay
在线阅读 下载PDF
REGULATING EFFECTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ANG Ⅱ ON FROG'S PERICARDIAL STOMATA, MESOTHELIUM AND ANGIOGENESIS 被引量:1
7
作者 李继承 周吉林 +2 位作者 BrunoTota GiusyScalia AlfonsinaGattuso 《Chinese Medical Sciences Journal》 CAS CSCD 2001年第1期23-28,共6页
To observe the regulating effects of vascular endothelial growth factor (VEGF) and angiotensinⅡ (ANG II) on the frog’s pericardium, lymphatic stomata and angiogenesis so as to reveal their effects and mechanism on t... To observe the regulating effects of vascular endothelial growth factor (VEGF) and angiotensinⅡ (ANG II) on the frog’s pericardium, lymphatic stomata and angiogenesis so as to reveal their effects and mechanism on the mesothelial permeability, lymphatic stoma regulation and myocardial hypertrophy. Methods. VEGF and ANGⅡ were injected into the frog’s peritoneal cavity so as to examine the changes of the pericardial stromata by using transmission electron microscopy, scanning electron microscopy and computerized imaging analysis. Results. Scattered distributed pericardial stomata were found on the parietal pericardium of the frog with a few sinusoid mesothelial cells, whose blood supply was directly from the cardiac chambers flowing into the trabecular spaces of the myocardium (because there are no blood vessels in the myocardium of the frog). The average diameters of the pericardial stomata in VEGF and ANGⅡ groups were 1.50μ m and 1.79μ m respectively, which were much larger than those in the control group (0.72μ m, P Conclusions. VEGF and ANGⅡ could strongly regulate the pericardial stomata by increasing their numbers and openings with larger diameters and higher distribution density. They could also increase the sinusoid areas with the result of the higher permeability of the pericardium, which clearly indicated that VEGF and ANGⅡ could speed up the material transfer of the pericardial cavity and play an important role in preventing myocardial interstitial edema. Yet there was no strong evidence to show the angiogenesis in the myocardium. 展开更多
关键词 vascular endothelial growth factor angioteinsin II lymphatic stomata
在线阅读 下载PDF
Vascular endothelial growth factor promotes angiogenesis in gastric carcinoma
8
作者 刘都户 张学庸 +2 位作者 黄峪新 粟永萍 樊代明 《Journal of Medical Colleges of PLA(China)》 CAS 2002年第1期73-78,共6页
Objective: To explore the role of vascular endothelial growth factor (VEGF) in the angiogenesis and development of human gastric carcinoma. Methods: The expressions of VEGF and its receptor KDR (ki-nase-domain insert ... Objective: To explore the role of vascular endothelial growth factor (VEGF) in the angiogenesis and development of human gastric carcinoma. Methods: The expressions of VEGF and its receptor KDR (ki-nase-domain insert containing receptor) in human gastric cancer tissue and SGC-7901 cells were detected with immunohistochemical staining. Microvessel density (MVD) was obtained after immunostaining for Factor-VIII. VEGF in SGC-7901 cell line was detected with Western blot. VEGF levels were manipulated in human gastric cancer cell by using eukaryotic expression vector containing the complete VEGF165 complimentary DNA in either the sense or antisense orientation. Finally the biological characteristics of the transfectants were identified. Results: VEGF-positive rate in TNM grade I and IV gastric carcinomas (19. 0%) were significantly higher than that in grade I and I (72. 4%) (P<0. 05). Increased MVD was found in VEGF-positive tumors (16. 4±6. 7). which is significantly larger than in VEGF-negative tumors (6. 5±2. 1) (P< 0. 05). Human gastric cancer cells (SGC-7901) produced 3 kinds of VEGF in molecule. In 2 cases of 50 specimens, a few gastric cancer cells expressed KDR in cytoplasm and cell membranes. SGC-7901 cells with anti-sense VEGF165 showed a significant reduction in cell surface VEGF protein with the immunofluorescence intensity from 8. 9% to 31. 6% (P<0. 05). However, those with stable integration of VEGF165 in the sense orientation resulted in an increase in cellular and cell surface VEGF with the immunofluorescence intensity from 75. 4% to 31. 6% (P<0. 05). The decrease of VEGF levels was associated with a marked decrease in the growth of nude mouse xenografted tumor (33 d post-implantation, 345. 4±136. 3 mm3 in size) (P<0. 05 vs control SGC-7901 group) , whereas VEGF overexpression resulted in an increase of xenografted tumor size (33 d post-implantation, 2 350. 5±637. 7 mm3 in size) (P<0. 05 vs control SGC-7901 group). Conclusion: VEGF plays an important role in the development of human gastric cancer, and might have an autocrine effect upon the gastric cancer cells. The inhibition of VEGF by antisense RNA expression might prevent solid tumor from growing and metastasizing. 展开更多
关键词 vascular endothelial growth factor ANGIOGENESIS stomach neoplasm
在线阅读 下载PDF
HEPATOCYTE GROWTH FACTOR PROTECTS AGAINST APOPTOSIS INDUCED BY ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS 被引量:2
9
作者 Yi-jun Zhou Jia-he Wang Jin Zhang 《Chinese Medical Sciences Journal》 CAS CSCD 2006年第1期6-10,共5页
Objective To investigate the effects of hepatocyte growth factor(HGF)on vascular endothelial cells apoptosis induced by advanced glycation end products(AGEs)and its possible mechanism. Methods Human umbilical vein end... Objective To investigate the effects of hepatocyte growth factor(HGF)on vascular endothelial cells apoptosis induced by advanced glycation end products(AGEs)and its possible mechanism. Methods Human umbilical vein endothelial cells(HUVECs)were cultured in vitro and intervened by different concentrations of AGEs and HGF.The cell inhibitory rates of each group with different culture time(12, 24, 48, and 72 hours)were measured by methyl thiazolyl tetrazolium(MTT)assay. The early stage apoptosis was detected by flow cytometry with Annexin V-FITC/PI double staining, morphology of cell apoptosis was observed by hoechst 33258 fluorescence staining, and the expression of apoptosis-associated genes Bax and Bcl-2 were determined by Western blotting.The activity of caspase-3 was detected by enzyme-linked immunosorbent assay (ELISA).Results Morphological observation indicated that high concentration of AGEs induced characteristic apoptotic changes in HUVECs.Within a certain concentration range, HUVECs apoptosis inducing rates by AGEs were in both dose- and time-dependent manners.HGF significantly inhibited the apoptosis of HUVECs induced by AGEs (P< 0.05).AGEs significantly promoted expression of Bax protein, but not Bcl-2.Whereas HGF significantly promoted the expression of Bcl-2(P<0.01)and decreased the activity of caspase-3(P<0.05)without affecting Bax level.Conclusions AGEs can induce the apoptosis of endothelial cells in vitro.HGF may effectively attenuate AGEs-induced endothelial cells apoptosis through upregulating Bcl-2 gene expression and inhibiting caspase-3 activation. 展开更多
关键词 hepatocyte growth factor advanced glycation end products vascular endothelial cell APOPTOSIS ATHEROSCLEROSIS
在线阅读 下载PDF
玻璃体内注射抗VEGF药物联合全视网膜激光光凝术(PRP)治疗不同程度中青年PDR患者的临床疗效
10
作者 石蕊 秦静 +2 位作者 龚小羽 李卓明 刘丹丹 《眼科新进展》 北大核心 2025年第3期216-220,共5页
目的探讨玻璃体内注射抗VEGF药物联合全视网膜激光光凝术(PRP)治疗不同严重程度的中青年增生型糖尿病视网膜病变(PDR)患者的临床疗效。方法本研究为回顾性病例研究,选取2021年1月1日至2024年10月1日就诊于陕西省人民医院眼科的糖尿病视... 目的探讨玻璃体内注射抗VEGF药物联合全视网膜激光光凝术(PRP)治疗不同严重程度的中青年增生型糖尿病视网膜病变(PDR)患者的临床疗效。方法本研究为回顾性病例研究,选取2021年1月1日至2024年10月1日就诊于陕西省人民医院眼科的糖尿病视网膜病变(DR)患者,依据我国糖尿病视网膜病变临床诊疗指南(2022年),将患者分为重度非增生型糖尿病视网膜病变组(NPDR组)、增生早期PDR组(E-PDR组)和纤维增生期DR组(F-PDR组),共纳入DR患者53例94眼,年龄(41.66±10.24)岁;其中,NPDR组17例31眼,E-PDR组18例33眼,F-PDR组18例30眼。所有患者均接受抗VEGF药物(雷珠单抗0.5 mg)玻璃体内注射,注射部位统一为颞下方角膜缘后3.5 mm,每月1次,连续3次,第1次注射后1周常规行PRP治疗,分别于第一次注射治疗后1个月、3个月进行最佳矫正视力[BCVA(logMAR)]、眼压监测以及裂隙灯检查、裂隙灯下眼底检查、欧堡照相及OCT检查,分别记录患者黄斑中心凹视网膜厚度(CMT)及平均厚度(AMT),玻璃体积血和视网膜前膜形成的发生率。结果与NPDR组和E-PDR组相比,F-PDR组患者年龄更小(均为P<0.05)。治疗后3个月,三组患眼BCVA较治疗前均有不同程度提高(均为P<0.05);治疗后3个月,与NPDR组及E-PDR组相比,F-PDR组患眼的视力预后更差,差异均有统计学意义(均为P<0.05)。治疗后3个月,三组患眼CMT及AMT均较治疗前明显降低(均为P<0.05),但三组患眼同时期组间比较差异均无统计学意义(均为P>0.05)。治疗后3个月,与NPDR组和E-PDR组相比,F-PDR组发生玻璃体积血及视网膜前膜的风险更高(均为P<0.05)。结论对于中青年PDR患者而言,玻璃体内抗VEGF药物注射联合PRP是早期控制病情进展的有效手段,可显著提高患者的视力;伴有纤维增殖的PDR患者进行抗VEGF药物注射联合PRP治疗时发生玻璃体积血和视网膜前膜的风险更高,需要严密随访,必要时需及时行玻璃体切割术解除视网膜牵拉。 展开更多
关键词 增生型糖尿病视网膜病变 全视网膜光凝 抗血管内皮生长因子药物 最佳矫正视力 黄斑中心凹视网膜厚度
在线阅读 下载PDF
Skeletal myoblast based delivery of angiogenic growth factors:a comparison between angiopoietin-1 and VEGF gene delivery for therapeutic angiogenesis in the heart 被引量:3
11
作者 Husnain Kh Haider In-Chin Song +1 位作者 Peter K Law Eugene KW Sim 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2006年第3期152-160,共9页
Objectives This study investigated the efficacy of human skeletal myoblasts (SkM) mediated either human vascular endothelial growth factor-165 (hVEGF165) or angiopoietin-1 (Ang-1) on vascular development and myocardia... Objectives This study investigated the efficacy of human skeletal myoblasts (SkM) mediated either human vascular endothelial growth factor-165 (hVEGF165) or angiopoietin-1 (Ang-1) on vascular development and myocardial regional perfusion. Methods A porcine heart model of chronic infarction was created in 28 female swine by coronary artery ligation. The animals were randomized into: (1) group-1, DMEM injected (n=6), (2) group-2, Ad-null transduced SkM transplanted (n=6), (3) group-3, Ad-hVEGF165 transduced SkM transplanted (n=8), and (4) group-4, Ad-Ang-1 transduced SkM (n=8). Three weeks later, 5 ml DMEM containing 3×108 SkM carrying exogenous genes were intramyocardially injected into 20 sites in left ventricle in groups-2, -3 and -4. Animals in group-1 were injected 5 ml DMEM without cells. Animals were kept on 5 mg/kg cyclosporine per day for 6 weeks. Regional blood flow was measured using fluorescent microspheres. The heart was explanted at 2, 6 and 12 weeks after transplantation for histological studies. Results Histological examination showed survival of lac-z expressing myoblasts in host tissue. Capillary density based on Von Willebrand factor-VIII (vWF-VIII) at low power field (×100) was 57.13±11.85 in group-3 at 6 weeks and declined to 32.1±5.21 at 12 weeks, while it was 39.9±10.26 at 6 weeks and increased to 45.14±6.54 at 12 weeks in group-4. The mature blood vessel index was highest in group- 4 at 6 and 12 weeks after transplantation. The regional blood flow in the center and peri-infarct area was significantly increased in animals of groups-3 and -4. Conclusions SkM carrying either hVEGF165 or Ang-1 induced neovascularization with increased blood flow. Ang-1 overexpression resulted in mature and stable blood vessel formation and may be a more potent arteriogenic inducer for neovascularization. 展开更多
关键词 therapeutic angiogenesis SKELETAL MYOBLASTS vascular endothelial growth factor-165 ANGIOPOIETIN-1 MYOCARDIAL INFARCTION
在线阅读 下载PDF
抗VEGF药物治疗糖尿病视网膜病变的伞状系统评价
12
作者 令娟 关婧楠 +2 位作者 罗向霞 谢卓霖 罗旭飞 《眼科新进展》 北大核心 2025年第2期108-114,共7页
目的对抗血管内皮生长因子药物(VEGF)治疗糖尿病视网膜病变(DR)的系统评价/Meta分析研究进行伞状系统评价,并以质量评价工具AMSTAR 2及PRISMA对文献质量进行评价,通过图表结合的形式展示证据质量的分布特征。方法计算机检索中英文数据库... 目的对抗血管内皮生长因子药物(VEGF)治疗糖尿病视网膜病变(DR)的系统评价/Meta分析研究进行伞状系统评价,并以质量评价工具AMSTAR 2及PRISMA对文献质量进行评价,通过图表结合的形式展示证据质量的分布特征。方法计算机检索中英文数据库,包括The Cochrane Library、PubMed、EMbase、CBM、万方及CNKI数据库,获取基于抗VEGF药物治疗DR的系统评价/Meta分析文献,检索时限均为建库至2024年3月。由2位评价员独立阅读文献并提取资料后,采用AMSTAR 2量表和PRISMA声明对纳入文献的方法学质量和报告质量进行伞状评价。结果最终纳入研究27篇,抗VEGF药物治疗DR系统评价/Meta分析的方法学质量及报告学质量为中等偏低质量。AMSTAR 2评价结果显示,对前期研究方案预先制定及纳入研究的资助来源等内容的阐述亟待提高;PRISMA结果显示,影响报告质量的条目内容主要为方案与注册、文献检索、补充分析与资助来源等。结论抗VEGF药物治疗DR的系统评价/Meta分析的方法学质量和报告学质量有待提高,在撰写系统评价/Meta分析的文章时研究者应当注意遵照AMSTAR 2量表和PRISMA声明要求以提升其方法学的质量和报告规范,从而提供更高质量证据等级的文献。 展开更多
关键词 抗血管内皮生长因子药物 糖尿病视网膜病变 伞状评价 AMSTAR 2 PRISMA
在线阅读 下载PDF
超声弹性成像联合血清VEGF、IL-17水平对甲状腺癌分化程度的鉴别效能
13
作者 林德威 张周龙 《罕少疾病杂志》 2025年第3期48-50,共3页
目的 分析超声弹性成像联合血清血管内皮生长因子(VEGF)、白细胞介素-17(IL-17)水平对甲状腺癌分化程度的鉴别效能。方法 回顾性研究本院收治的268例甲状腺癌患者的临床资料,参照临床判断结果将其分为中/高分化组(187例)、低分化组(81例... 目的 分析超声弹性成像联合血清血管内皮生长因子(VEGF)、白细胞介素-17(IL-17)水平对甲状腺癌分化程度的鉴别效能。方法 回顾性研究本院收治的268例甲状腺癌患者的临床资料,参照临床判断结果将其分为中/高分化组(187例)、低分化组(81例)。比较两组患者超声弹性成像相关参数(弹性比值、蓝色面积比值)以及血清VEGF、IL-17水平;绘制受试者工作特征(ROC)曲线分析超声弹性成像、血清VEGF、IL-17单独及联合对甲状腺癌分化程度的鉴别价值。结果 中/高分化组的弹性比值、蓝色面积比值、血清VEGF和IL-17水平均低于低分化组(P<0.05)。弹性比值、蓝色面积比值联合鉴别甲状腺癌分化程度的曲线下面积(AUC)、灵敏度、特异度分别为0.901、85.19%、87.70%,其中联合灵敏度高于单独单独鉴别,联合AUC高于单独鉴别(P<0.05),特异度与单独鉴别相近;超声弹性成像参数联合血清VEGF、IL-17鉴别甲状腺癌分化程度的的AUC、灵敏度、特异度分别为0.963、96.30%、84.49%,其中联合灵敏度高于单独单独鉴别,联合AUC高于单独鉴别(P<0.05),特异度与单独鉴别相近。结论 超声弹性成像参数与血清VEGF、IL-17均可有效鉴别甲状腺癌分化程度,但其联合鉴别价值更高。 展开更多
关键词 甲状腺癌 超声弹性成像 血管内皮生长因子 白细胞介素-17 分化程度 鉴别效能
在线阅读 下载PDF
多波长眼底激光联合抗VEGF对糖尿病视网膜病变患者玻璃体黄斑界面的影响研究
14
作者 李雨 孙冬敏 李英俊 《临床眼科杂志》 2025年第1期13-16,共4页
目的探讨多波长眼底激光联合抗血管内皮生长因子(VEGF)在糖尿病视网膜病变(DR)患者中的效果及对玻璃体黄斑界面(VMI)的影响。方法前瞻性病例对照研究。选择2023年7~11月DR患者100例(100只眼)为研究对象,信封法分为两组各50例。对照组采... 目的探讨多波长眼底激光联合抗血管内皮生长因子(VEGF)在糖尿病视网膜病变(DR)患者中的效果及对玻璃体黄斑界面(VMI)的影响。方法前瞻性病例对照研究。选择2023年7~11月DR患者100例(100只眼)为研究对象,信封法分为两组各50例。对照组采取多波长眼底激光治疗,观察组联合抗VEGF治疗,两组治疗5周后评估患者效果,比较两组最佳矫正视力(BCVA)、症状消失时间、视网膜中央动、静脉血流动力学参数、玻璃体黄斑界面及并发症发生率。结果观察组干预5周后BCVA高于对照组(P<0.05);眼底出血吸收、渗出吸收及黄斑水肿改善时间短于对照组(均P<0.05);观察组干预5周后动脉视网膜中央动脉峰值血流速度(PSV)、平均血流速度(MV)、舒张末期血流速度(EDV)和中央静脉最大血流速度(Vmax)、最低血流速度(Vmin)及(MV水平)低于对照组(均P<0.05);静脉波动指数(PI)及阻力指数(RI)低于对照组(均P<0.05);观察组VIM、黄斑水肿、玻璃体出血、视网膜出血及新的无灌注区发生率低于对照组(均P<0.05)。结论多波长眼底激光联合抗VEGF能缩短DR患者症状消失时间,提高BCVA,改善视网膜中央动、静脉血流动力学水平,能降低VMI发生率,且患者治疗安全性较高,值得推广应用。 展开更多
关键词 多波长眼底激光 抗血管内皮生长因子 糖尿病视网膜病变 玻璃体黄斑界面
在线阅读 下载PDF
评估术前血清VEGF与系统性免疫炎症指数对原发性肝癌术后预后的预测价值
15
作者 王爽 张彬 黄利 《罕少疾病杂志》 2025年第4期84-86,共3页
目的探讨血管内皮生长因子(VEGF)与全身炎症指数(SⅡ)在原发性肝癌(PHC)术后的预后价值。方法回顾性分析2018年1月至2020年1月在本院进行手术治疗的164例PHC患者的临床资料。使用Logistic回归模型分析PHC患者术后复发的影响因素。采用... 目的探讨血管内皮生长因子(VEGF)与全身炎症指数(SⅡ)在原发性肝癌(PHC)术后的预后价值。方法回顾性分析2018年1月至2020年1月在本院进行手术治疗的164例PHC患者的临床资料。使用Logistic回归模型分析PHC患者术后复发的影响因素。采用受试者工作特征曲线(ROC)分析危险因素在预测患者复发的价值。结果Logistic回归分析显示,年龄、Child-pugh B级、VEGF、SⅡ和AFP是PHC患者术后独立的复发危险因素(P<0.05)。ROC曲线分析显示,VEGF(AUC=0.791)和SⅡ(AUC=0.687)可以预测PHC患者的术后复发,并且VEGF的AUC与联合曲线比较无差异(P>0.05)。结论年龄、Child-pugh B级、VEGF、SII和甲胎蛋白是影响患者独立预后的因素,VEGF的表达可作为PHC患者术后的复发的潜在预测指标。 展开更多
关键词 原发性肝癌 血管内皮生长因子 全身炎症指数 术后复发
在线阅读 下载PDF
MSCT检查联合proGRP、VEGF及PTX-3检测在肺癌诊断及预后评估中的应用
16
作者 郭范伟 丁威 李士华 《四川生理科学杂志》 2025年第1期142-145,共4页
目的:研究多层螺旋CT(Multisliecs helieal CT,MSCT)检查联合胃泌素释放肽前体(Gastrin-releasing peptide precursor,pro-GRP)、血管内皮生长因子(Vascular endothelial growth factor,VEGF)及正五聚蛋白3(Pentraxin-3,PTX-3)检测在肺... 目的:研究多层螺旋CT(Multisliecs helieal CT,MSCT)检查联合胃泌素释放肽前体(Gastrin-releasing peptide precursor,pro-GRP)、血管内皮生长因子(Vascular endothelial growth factor,VEGF)及正五聚蛋白3(Pentraxin-3,PTX-3)检测在肺癌诊断及预后评估中的应用价值。方法:选取2021年3月-2023年3月期间本院收治的非小细胞肺癌患者158例。比较肺癌不同分期患者MSCT参数、血清proGRP、VEGF及PTX-3水平;分析MSCT参数、血清proGRP、VEGF及PTX-3单独及联合检测对肺癌的诊断效能;分析影响肺癌患者预后的单因素、危险因素;分析血清proGRP、VEGF、PTX-3及MSCT单独及联合对肺癌的预后价值。结果:Ⅲ期-Ⅳ期血清proGRP、VEGF、PTX-3水平及MSCT的CT值均比Ⅰ期-Ⅱ期高(P<0.05)。proGRP+VEGF+PTX-3+MSCT检测敏感性及特异性分别为94.74%、90.48%,均高于proGRP、VEGF、PTX-3、MSCT单一检测。158例肺癌患者中,预后不良组43例,预后好转组115例。两组年龄、性别、病理类型比较差异无统计学意义(P>0.05),两组吸烟、临床分期、proGRP、VEGF、PTX-3水平及MSCT的CT值比较差异有统计学意义(P<0.05)。经多元Logistic回归分析显示:吸烟、临床分期为Ⅲ期-Ⅳ期、pro-GRP≥46 pg·mL^(-1)、VEGF>142 ng·mL^(-1)、PTX-3升高及MSCT的CT值升高是影响肺癌患者预后的危险因素(P<0.05)proGRP+VEGF+PTX-3+MSCT预后敏感性及特异性分别为94.68%、90.62%,均高于proGRP、VEGF、PTX-3、MSCT单一检测。结论:MSCT影像检查联合proGRP、VEGF及PTX-3检测在肺癌诊断中具有较高价值,同时临床可通过检测MSCT参数和proGRP、VEGF、PTX-3水平来评估肺癌患者预后。 展开更多
关键词 MSCT 胃泌素释放肽前体 血管内皮生长因子 正五聚蛋白3 肺癌
在线阅读 下载PDF
多次玻璃体内注射抗VEGF药物对眼底血管性疾病患者角膜组织形态的影响 被引量:4
17
作者 祁媛媛 闫春晓 +3 位作者 金翠华 袁琳慧 李胜 张立军 《眼科新进展》 CAS 北大核心 2024年第3期230-234,共5页
目的 探讨多次玻璃体内注射雷珠单抗和阿柏西普对湿性老年性黄斑变性(nAMD)、糖尿病黄斑水肿(DME)、视网膜静脉阻塞(RVO)患者角膜组织形态的影响。方法 前瞻性临床研究。选取2021年6月至2022年6月在我院眼内科注射中心治疗的患者共64例... 目的 探讨多次玻璃体内注射雷珠单抗和阿柏西普对湿性老年性黄斑变性(nAMD)、糖尿病黄斑水肿(DME)、视网膜静脉阻塞(RVO)患者角膜组织形态的影响。方法 前瞻性临床研究。选取2021年6月至2022年6月在我院眼内科注射中心治疗的患者共64例(64眼)作为研究对象;其中nAMD患者19例,DME患者20例,RVO患者25例。阿柏西普(40 g·L^(-1))治疗29例,雷珠单抗(10 g·L^(-1))治疗35例。所有入组病例均选取单眼注射,采取3+PRN的随访治疗方法。使用共聚焦显微镜行角膜神经检查,使用角膜内皮显微镜进行角膜厚度及角膜内皮细胞检查。比较nAMD、DME、RVO患者多次玻璃体内注射抗VEGF药物后角膜厚度、内皮细胞密度、变异系数、平均面积、六角形细胞比例、神经纤维长度、神经纤维密度,比较每次注射不同药物后1个月与基线时上述指标变化。结果 术前,DME组患者内皮细胞密度低于nAMD组和RVO组,DME组患者内皮细胞平均面积高于nAMD组和RVO组,差异均有统计学意义(均为P<0.05),三种不同疾病患者其余指标差异均无统计学意义(均为P>0.05)。注射抗VEGF药物3次后,DME组患者内皮细胞密度低于nAMD组和RVO组,内皮细胞平均面积高于nAMD组和RVO组,差异均有统计学意义(均为P<0.05);DME组患者神经纤维长度短于nAMD组和RVO组,差异均有统计学意义(均为P<0.05)。自从第2次注射阿柏西普后,nAMD组患者内皮细胞密度均较术前减少,差异均有统计学意义(均为P<0.05);每次注射后六角形细胞比例均较术前减少,差异均有统计学意义(均为P<0.05);其余指标注射后与术前相比,差异均无统计学意义(均为P>0.05)。自从第2次注射雷珠单抗后,RVO组患者内皮细胞密度均较术前减少,差异均有统计学意义(均为P<0.05)。结论 多次玻璃体内注射抗VEGF药物会一定程度降低角膜内皮六角形细胞比例及内皮细胞密度,注射药物后DME组的神经纤维长度显著低于nAMD组和RVO组。 展开更多
关键词 抗血管内皮生长因子 内皮细胞密度 角膜神经 阿柏西普 雷珠单抗
在线阅读 下载PDF
经钻孔引流术治疗慢性硬膜下血肿患者血清TSP1、TSP2、bFGF、VEGF、S-100β水平变化及其临床意义 被引量:1
18
作者 吴颐 叶明 +1 位作者 高觉民 李建 《分子影像学杂志》 2024年第4期341-347,共7页
目的探讨经钻孔引流术治疗慢性硬膜下血肿患者血清血小板反应蛋白1(TSP1)、血小板反应蛋白2(TSP2)、碱性成纤维细胞生长因子(bFGF)、血管内皮生长因子(VEGF)、中枢神经特异蛋白(S-100β)水平变化及其临床意义。方法选取江苏省中医院2019... 目的探讨经钻孔引流术治疗慢性硬膜下血肿患者血清血小板反应蛋白1(TSP1)、血小板反应蛋白2(TSP2)、碱性成纤维细胞生长因子(bFGF)、血管内皮生长因子(VEGF)、中枢神经特异蛋白(S-100β)水平变化及其临床意义。方法选取江苏省中医院2019年1月~2023年6月收治的慢性硬膜下血肿患者142例作为病例组,均进行钻孔引流术;另选取同期健康体检人员146例作为健康对照组,比较两组不同脑损伤、手术前后、不同复发情况的血清TSP1、TSP2、bFGF、VEGF、S-100β水平,分析血清TSP1、TSP2、bFGF、VEGF、S-100β水平与慢性硬膜下血肿患者脑损伤程度的相关性。结果与健康对照组比较,病例组血清TSP1、TSP2、bFGF、VEGF、S-100β水平均相对更高;与轻度脑损伤组进行比较,中度脑损伤组、重度脑损伤组血清TSP1、TSP2、bFGF、VEGF、S-100β水平均相对更高,且重度脑损伤组高于中度脑损伤组;与术前进行比较,术后7 d慢性硬膜下血肿患者血清TSP1、TSP2、bFGF、VEGF、S-100β水平均相对较低;与复发组进行比较,未复发组血清TSP1、TSP2、bFGF、VEGF、S-100β水平均相对较低(P<0.05)。Pearson相关分析结果显示,慢性硬膜下血肿患者血清TSP1、TSP2、bFGF、VEGF、S-100β水平与GCS评分均呈负相关关系(r=-0.655、-0.674、-0.711、-0.689、-0.705,P<0.05)。结论慢性硬膜下血肿患者经钻孔引流术后血清TSP1、TSP2、bFGF、VEGF、S-100β水平均降低,并与患者脑损伤程度、转归具有高度相关性,临床上可通过检测慢性硬膜下血肿患者上述各项血清学指标的变化情况,以便及时判断慢性硬膜下血肿患者的脑损伤程度。 展开更多
关键词 硬膜下血肿 慢性 经钻孔引流术 血小板反应蛋白1 血小板反应蛋白2 碱性成纤维细胞生长因子 血管内皮生长因子 中枢神经特异蛋白
在线阅读 下载PDF
电针治疗调节miR-183对噪声性耳聋模型耳蜗毛细胞VEGF表达的影响
19
作者 王荣国 高洁 +1 位作者 张慧平 屈永涛 《皖南医学院学报》 CAS 2024年第5期409-413,共5页
目的:探讨电针治疗调节miR-183对噪声性耳聋(NIHL)模型耳蜗毛细胞血管内皮生长因子(VEGF)表达的影响与作用机制。方法:将雄性SD大鼠随机均分为空白对照组、NIHL组、NIHL+针刺组、NIHL+针刺+腺病毒(AAV)-NC组和NIHL+针刺+AAV-sp-miR-183... 目的:探讨电针治疗调节miR-183对噪声性耳聋(NIHL)模型耳蜗毛细胞血管内皮生长因子(VEGF)表达的影响与作用机制。方法:将雄性SD大鼠随机均分为空白对照组、NIHL组、NIHL+针刺组、NIHL+针刺+腺病毒(AAV)-NC组和NIHL+针刺+AAV-sp-miR-183组。针刺组取中渚穴进行刺激。利用AAV载体在NIHL大鼠中敲低miR-183。各组大鼠进行听觉脑干反应(ABR)评估与毛细胞计数。qRT-PCR分析大鼠耳蜗组织miR-183水平。蛋白质免疫印迹测定VEGF水平。结果:与对照组相比,NIHL组耳蜗组织中miR-183的水平降低,ABR阈值差与毛细胞的缺失率升高,耳蜗毛细胞VEGF表达的水平升高(P<0.05)。与NIHL组相比,NIHL+针刺组耳蜗组织中miR-183的水平上升,ABR阈值差与毛细胞的缺失率降低,耳蜗毛细胞VEGF表达的水平升高(P<0.05)。NIHL+针刺+AAV-sp-miR-183组与NIHL+针刺+AAV-NC组相比,miR-183的水平降低,ABR阈值差与毛细胞的缺失率升高,耳蜗毛细胞VEGF表达的水平降低(P<0.05)。结论:电针治疗可以通过上调miR-183进而促进NIHL大鼠耳蜗毛细胞VEGF的表达,降低噪音诱导的NIHL大鼠ABR阈值差增高与毛细胞损伤。 展开更多
关键词 电针治疗 噪声性耳聋 miR-183 耳蜗毛细胞 血管内皮生长因子
在线阅读 下载PDF
信迪利单抗联合贝伐珠单抗治疗不可切除肝细胞肝癌患者效果及其血清VEGF、MMP-9水平变化
20
作者 董伯升 徐克友 +1 位作者 张静 张淼 《河南医学研究》 CAS 2024年第3期524-528,共5页
目的 探讨信迪利单抗联合贝伐珠单抗治疗不可切除肝细胞肝癌患者效果及其血清血管内皮生长因子(VEGF)、基质金属蛋白酶-9(MMP-9)水平变化。方法 选取2021年1月至2022年12月在周口市中心医院确诊的80例不可切除肝细胞肝癌患者,根据患者... 目的 探讨信迪利单抗联合贝伐珠单抗治疗不可切除肝细胞肝癌患者效果及其血清血管内皮生长因子(VEGF)、基质金属蛋白酶-9(MMP-9)水平变化。方法 选取2021年1月至2022年12月在周口市中心医院确诊的80例不可切除肝细胞肝癌患者,根据患者治疗方式将患者分为单抗联合组和对照组。对照组患者接受口服甲苯磺酸索拉非尼治疗,纳入36例;单抗联合组接受信迪利单抗联合贝伐珠单抗治疗,纳入44例。记录两组患者治疗4个周期后的病情控制率和客观缓解率,比较治疗前、治疗2个周期后、治疗4个周期后血清VEGF和MMP-9水平变化,比较治疗毒副作用发生情况。随访6~30个月,绘制生存曲线,比较两组患者中位总生存时间(OS)和中位无进展生存时间(PFS)。结果 单抗联合组患者病情控制率和客观缓解率分别为77.27%和25.00%,对照组分别为44.44%和5.56%,差异有统计学意义(P<0.05)。治疗后,单抗联合组患者血清VEGF和MMP-9水平均随着时间降低,且低于对照组,差异有统计学意义(P<0.05)。单抗联合组患者甲状腺功能减退发生率为18.18%,对照组为2.78%,差异有统计学意义(P<0.05);单抗联合组患者脱发和手足综合征发生率均为0,对照组分别为22.22%和27.78%,差异均有统计学意义(P<0.05)。所有患者中位随访时间为18个月,单抗联合组患者中位OS和中位PFS分别为16.9个月和4.8个月,对照组患者中位OS和中位PFS分别为10.5个月和3个月,两组比较差异有统计学意义(P<0.05)。结论 信迪利单抗联合贝伐珠单抗治疗可以较好地控制不可切除肝细胞肝癌患者病情发展,显著降低血清肿瘤相关因子水平,提高生存率,且安全性较好。 展开更多
关键词 信迪利单抗 贝伐珠单抗 肝癌 血管内皮生长因子 基质金属蛋白酶-9
在线阅读 下载PDF
上一页 1 2 91 下一页 到第
使用帮助 返回顶部